Skip to main content
Log in

Association of NK Cell Dysfunction with Changes in LDH Characteristics of Peripheral Blood Lymphocytes (PBL) in Breast Cancer Patients

  • Conference Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The cytotoxic activity of NK (natural killer) cells is very important in immunological surveillance against the appearance and especially the spread of malignant disease. The aim of this study was to investigate the function of this subpopulation of cells in breast cancer patients in different clinical stages of disease prior to therapy. NK cell activity was determined in breast cancer patients and healthy controls by three different methods: standard 51-chromium-release assay and by the original colorimetric uncorrected and corrected lactate dehydrogenase (LDH) release assay. A discrepancy was shown between the assays, as the uncorrected LDH assay showed, not only, much higher values, but no stage-dependent depression in NK cell activity compared to the chromium-release assay. Further analyses of separately cultured peripheral blood lymphocytes (PBL) revealed that this difference arose from an increasing, clinical stage-dependent, spontaneous LDH release from PBL of breast cancer patients. Furthermore, a stage-dependent increase in intracellular LDH activity of PBL was found, although without difference in LDH-H and LDH-M isotype ratio, compared to controls. Increased spontaneous LDH release and intracellular LDH activity was more evident in young patients, under 40 years. Correction of the original LDH-release assay for the spontaneous LDH release activity from PBL present in the assay, gave values of NK cell activity comparable to those determined by the chromium assay and indicated that breast cancer patients have a significant depression in NK cell activity which correlates with the stage-dependent increase in spontaneous LDH release. Moreover, as both assays measure the secretory, perforin-mediated, NK cell cytotoxic pathway against tumor cells, it can be concluded that the appearance of spontaneous LDH release is an indicator of cell membrane damage which not only allows the loss of LDH, but also of the components of the secretory killing pathway, resulting in NK cell dysfunction with the progression of disease. The novel findings obtained in this work reveal the association of PBL membrane damage with clinical stage of breast cancer that can, aside from reflecting NK cell depression, underlie the defect in other PBL subsets and subsequently facilitate progression of the malignant process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Whiteside T, Herberman R: The role of natural killer cells in immune surveilance of cancer. Curr Opin Immunol 7: 704-710, 1995

    Google Scholar 

  2. Smyth MJ, Thia Ky, Cretney E, Kelly JM, Snook MB, Forbes CA, Scalzo AA: Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol 162: 6658-6662, 1999

    Google Scholar 

  3. Divino CM, Chen SH, Yang W, Thung S, Brower S, Woo LCS: Anti-tumor immunity induced by interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells. Breast Cancer Res Treat 60: 129-134, 2000

    Google Scholar 

  4. Lotsova E: Natural killer cells: immunobiology and clinical prospects. Cancer Invest 9: 173-184, 1991

    Google Scholar 

  5. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. (Review article) Blood 76: 2421-2451, 1990

    Google Scholar 

  6. Ortaldo JR, Winker R, Morgen C, Woodhouse C, Cantor R, Raynolds C: Analysis of rat NKCF produced by rat NK cell lines and production of a murine monoclonal antibody. J Immunol 139: 3159-3162, 1987

    Google Scholar 

  7. Brenner BG, Friedman G, Margolese RG: The relationships of clinical status and therapeutic modality to natural killer cell activity in human breast cancer. Cancer 56: 1543-1547, 1985

    Google Scholar 

  8. Konjević, G, Spužić I: Stade dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer. Neoplasma 40: 81-85, 1993

    Google Scholar 

  9. Ross ME, Caligiuri MA: Citokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89: 910-918, 1997

    Google Scholar 

  10. Schlicther LC: Acute exposure to human interferon-alpha effects ion current in human natural killer cells. Can J Physiol Pharmacol 70: 365-376, 1992

    Google Scholar 

  11. Xue Q, Yeung ES: Determination of lactate dehydrogenase isoenzymes in single lymphocytes from normal and leukemia cell lines. J Chromatogr 677: 233-240, 1996

    Google Scholar 

  12. Pan LX, Xu JN, Isaacson PG: Cellular H and M type lactate dehydrogenase (LDH) isoenzymes and tumor diagnosis an immunohistochemical assessment. J Pathol 163: 53-60, 1991

    Google Scholar 

  13. Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV: C-myc transactivation of LDHA: implications for tumor metabolism and growth. Proc Natl Acad Sci USA 94: 6658-6663, 1997

    Google Scholar 

  14. Wollberg P, Nelson BD: Regulation of the expression of lactate dehydrogenase isozymes in human lymphocytes. Mol Cell Biochem 110: 161-164, 1992

    Google Scholar 

  15. Marjanović S, Skog S, Heiden T, Tribukait B, Nelson BD: Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: Cell cycle analysis using flow cytometry, Exp Cell Res 193: 425-431, 1991

    Google Scholar 

  16. Huang D, Jungmann RA: Transcriptional regulation of the lactate dehydrogenase A subunit gene by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Mol Cell Endocrin 108: 87-94, 1995

    Google Scholar 

  17. Marjanović S, Wielburski A, Nelson BD: Effect of phorbol myristate acetate and concanavalin A on the glycolytic enzymes of human peripheral lymphocytes. Biochem Biophys Acta 970: 1-6, 1988

    Google Scholar 

  18. Jurišić V, Spužić I, Konjević G. A comparison of the NK cell cytotoxicity with with effects of TNF-? against K-562 cells, determined by LDH release assay. Cancer Lett 138: 67-72, 1999

    Google Scholar 

  19. Korzeniewski C, Callewaert DM: An enzyme-release assay for natural cytotoxity. J Immunol Meth 64: 313-320, 1983

    Google Scholar 

  20. Konjević G, Jurišić V, Spužić I: Correction to the original lactate dehydrogenase (LDH) release assay for evaluation of NK cell cytotoxicity. J Immunol Meth 200: 199-201, 1997

    Google Scholar 

  21. Buhl SN, Jackson KY: Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30 and 37°C. Clin Chem 24: 828-831, 1978

    Google Scholar 

  22. Gutmann I, Wahlefeld AW: L(+)lactate determination with lactate dehydrogenase and NAD+. In: Bergemeyer HU (ed) Methods of enzymatic analysis. 1464-1472, 1974

  23. Decker T, Lohmann-Matthes ML: A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Meth 115: 61-69, 1988

    Google Scholar 

  24. Konjević G, Jurišić V, Banićević B, Spužić I: Diffference in NK cell activity between patients with Non-Hodgkin's and Hodgkin's lymphomas. Br J Haematol 109: 101-104, 1999

    Google Scholar 

  25. Hoek A, van Kasteren Y, de Haan-Meulman M, Hooijkaas H, Schoemaker J, Drexhage HA: Analysis of peripheral blood lymphocyte subsets, NK cells, and delayed type hypersensitivity skin test in patients with premature ovarian failure. Am J Reprod Immunol 33(6): 495-502, 1995

    Google Scholar 

  26. Luka J, Kusi Z, Kordi D, Konar M. Bolana A: Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 29: 279-285, 1994

    Google Scholar 

  27. Brennner BG, Benarrosh S, Margolese RG: Peripheral blood NK cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma. Cancer 26: 895-899, 1986

    Google Scholar 

  28. Pan L, Beverley PCL, Isaacson PG: Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells-an immunocytochemical study. Clin Exp Immunol 86: 240-245, 1991

    Google Scholar 

  29. Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, Belichard C, Jeannin JF: Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment. Cytokine 79: 540-543, 1998

    Google Scholar 

  30. Camp BJ, Dyhrman ST, Memoli VA, Mott LA, Bart RJ: In situ cytokines production by breast cancer tumor-infiltrating lymphocytes. Ann Surg Oncol 1392: 176-184, 1996

    Google Scholar 

  31. Gabelman BM, Emerman JT: Effects of estrogen, epidermal growth factor, and transforming growth factor-alpha on the growth of human breast epithelial cells in primary culture. Exp Cell Res 201(1): 113-118, 1992

    Google Scholar 

  32. Nehar D, Mauduit C, Revol A, Morera AM, Behahmed M: Effect of epidermal growth factor/transforming growth factor alpha on lactate production in porcine Sertoli cells: glucose transport and lactate dehydrogenase isozymes as potential sites of action. Mol Cell Endocrinol 92: 45-53, 1993

    Google Scholar 

  33. Nehar D, Mauduit C, Boussouar F, Benahmed M: Tumor necrosis factor-alpha-stimulated lactate production is linked to lactate dehydrogenase A expression and activity increase in porcine cultured Sertoli cells. Endocrinology 138: 1964-1971, 1997

    Google Scholar 

  34. Juriši´c V, Konjević G, Bani´cević B, DjurićiŰ B, Spužić I: Different alteration in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin's and non-Hodgkin's lymphomas. Eur J Haematol 64: 259-266, 2000

    Google Scholar 

  35. Bogin L, Papa MZ, Polak-Charcon S, Degani H: TNF-induced modulations of phospholipid metabolism in human breast cancer cells. Biochim Biophys Acta 1392: 217-232, 1998

    Google Scholar 

  36. Santanavere E, di-Pietro R, Domenicantonio L, Rana R: Sensitivity of Daudi cells to tumor necrosis factor alpha: early changes in polyphosphoinositide metabolism. Cell Biol Int 20: 643-646, 1996

    Google Scholar 

  37. Binder C, Schulz M, Hiddemann W, Oellerich M: Induction of inducible nitric oxide syntetase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. Lab Invest 79: 1703-1712, 1999

    Google Scholar 

  38. Johnson-Voelker C. Entingh A, Wold WSM, Gooding LR, Laster SM: Activation of intracellular proteases is a early event in TNF-induced apoptosis. J Immunol 154: 1707-1716, 1995

    Google Scholar 

  39. Scherzer JA, Lin Y, Leish KR, Klein J: TNF translationally modulates the expression of G1 protein alpha 1,2 subunits in human polymorphonuclear leukocytes. J Immunol 158: 913-918, 1997

    Google Scholar 

  40. Kaplan O, Jaroszewski JW, Faustino PJ, Zugmaier G, Ennis BW, Lippman M, Cohen JS: Toxicity and effects of epidermal growth factor on glucose metabolism of MDA-468 human breast cancer cells. J Biol Chem 15: 136-139, 1990

    Google Scholar 

  41. Hess SD, Oortgiesen M, Cahalan MD: Calcium oscillation in human T and natural killer cells depend upon membrane potential and calcium influx. J Immunol 150: 2620-2625, 1993

    Google Scholar 

  42. Bareett M, Walmsley AR, Gould GW: Structure and function of facilitative sugar transport. Current opinion in Cell Biology 11: 496-502, 1999

    Google Scholar 

  43. Benten WP, Leiberherr M, Giese G, Wunderlich F: Estradiol binding to cell surface raises cytosolic free calcuim in T cells. FEBS Lett 422(3): 349-353, 1998

    Google Scholar 

  44. Higgins CF: Membrane permeability transporters and channels: from disease to structure and back. Curr Opin Biol 11: 495-499, 1999

    Google Scholar 

  45. Reimman, Ashcroft FM: Inwardly potassium channels. Curr Opin Cell Biol 11: 503-508, 1999

    Google Scholar 

  46. Evans MJ, MacLaughlin S, Marvin RD, Abdou NI: Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin Immunol Immunopathol 82: 258-262, 1997.

    Google Scholar 

  47. Komlos L, Zahavi Z, Dicker D, Luria D, Salman H, Zahavi I: In vitro modulation of activation antigens on human lymphocytes by beta-estradiol. Am J Reprod Immunol 40: 418-423, 1998

    Google Scholar 

  48. Singh MM, Trivedi RN, Chauhan SC, Srivastava VM, Makker A, Chowdhury SR, Kamboj VP: Uterine estradiol and progesterone receptor concentration, activities of certain antioxidant enzymes and dehydrogenases and histoarchitecture in relation to time of secretion of nidatory estrogen and high endometrial sensitivity in rat. J Steroid Biochem Mol Biol 59: 215-224, 1996

    Google Scholar 

  49. Reyburn H, Mandelboim Vales-Gomez M. Sheu EG, Pazmany L, Davis DM, Strominger JL: Human NK cells: their ligand, receptors and functions. Immunol Rev 155: 119-125, 1997

    Google Scholar 

  50. Sulica A, Chambers WH, Manciulea M, Metes D, Corey S, Rabinowich H, Whiteside TL, Herberman RB: Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies. Nat Immunol 14: 123-133, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konjević, G., Jurišić, V. & Spužić, I. Association of NK Cell Dysfunction with Changes in LDH Characteristics of Peripheral Blood Lymphocytes (PBL) in Breast Cancer Patients. Breast Cancer Res Treat 66, 255–263 (2001). https://doi.org/10.1023/A:1010602822483

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010602822483

Navigation